- Home
- ETON vs CLCO Comparison
ETON vs CLCO Comparison
Compare ETON & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- CLCO
- Stock Information
- Founded
- ETON 2017
- CLCO 2018
- Country
- ETON United States
- CLCO United Kingdom
- Employees
- ETON N/A
- CLCO N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- CLCO
- Sector
- ETON Health Care
- CLCO
- Exchange
- ETON Nasdaq
- CLCO Nasdaq
- Market Cap
- ETON 428.5M
- CLCO 285.3M
- IPO Year
- ETON 2018
- CLCO N/A
- Fundamental
- Price
- ETON $17.14
- CLCO $6.30
- Analyst Decision
- ETON Strong Buy
- CLCO
- Analyst Count
- ETON 3
- CLCO 0
- Target Price
- ETON $27.67
- CLCO N/A
- AVG Volume (30 Days)
- ETON 221.4K
- CLCO 137.5K
- Earning Date
- ETON 05-13-2025
- CLCO 05-21-2025
- Dividend Yield
- ETON N/A
- CLCO 9.77%
- EPS Growth
- ETON N/A
- CLCO N/A
- EPS
- ETON N/A
- CLCO 1.82
- Revenue
- ETON $39,011,000.00
- CLCO $322,510,000.00
- Revenue This Year
- ETON $92.33
- CLCO $2.03
- Revenue Next Year
- ETON $52.62
- CLCO N/A
- P/E Ratio
- ETON N/A
- CLCO $3.37
- Revenue Growth
- ETON 23.29
- CLCO N/A
- 52 Week Low
- ETON $3.18
- CLCO $4.51
- 52 Week High
- ETON $18.41
- CLCO $13.68
- Technical
- Relative Strength Index (RSI)
- ETON 70.21
- CLCO 62.76
- Support Level
- ETON $16.43
- CLCO $5.95
- Resistance Level
- ETON $17.49
- CLCO $6.27
- Average True Range (ATR)
- ETON 0.85
- CLCO 0.22
- MACD
- ETON 0.18
- CLCO 0.06
- Stochastic Oscillator
- ETON 98.09
- CLCO 83.74
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.